Dow Up 0.51% Nasdaq Up 0.24%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
10.33 Down 0.02(0.19%) Nov 21, 4:00PM EST
|After Hours : 10.33 Up 0.00 (0.01%) Nov 21, 4:45PM EST
Prev Close:10.35
Open:10.53
Bid:8.98 x 500
Ask:N/A
1y Target Est:17.73
Beta:5.1
Next Earnings Date:18-Feb-15BCRX Earnings announcement
Day's Range:10.11 - 10.53
52wk Range:5.63 - 14.62
Volume:516,261
Avg Vol (3m):1,214,390
Market Cap:742.34M
P/E (ttm):N/A
EPS (ttm):-0.61
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BCRXDown 0.19%742.34M
GSKUp 0.04%111.55B
RHHBYDown 1.04%253.38B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):39.71
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.74
Quarterly EPS Est (Dec-14) :-0.22
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-1.94

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback